German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
about
Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancerAdjuvant bisphosphonates in patients with breast cancer: does the potency matter?Bisphosphonates in breast cancerBisphosphonate and risk of cancer recurrence: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trialsBone-Targeted TherapyBone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myelomaHigher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.Targeted and Osteo-Oncologic Treatment in Early Breast Cancer: What Is State-of-the-Art and What Might Become so within the Next 5 Years?Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical PracticeThe Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany.Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meetingBRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial.Bayesian survival analysis in clinical trials: What methods are used in practice?Bone Modifier Use as Adjuvant Therapy for Early Breast Cancer.Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study.Bisphosphonate use and risk of recurrence, second primary breast cancer, and breast cancer mortality in a population-based cohort of breast cancer patients.Bisphosphonates and other bone agents for breast cancer.
P2860
Q26746212-B807B497-081B-4510-A8C8-8D420F7825C7Q26781435-5E3EA158-0905-4B5C-9C93-5B53B8702ADAQ26859326-113795FE-29F7-4E29-B34D-12DDC50C8243Q26861586-FEC582DC-74DF-4C02-8C17-9192CCB03B58Q28081294-5B9F6918-10BE-48DF-8470-743B9FC2F1CBQ28081996-C6A728B2-BAC3-489B-A91A-50832AE8A1FFQ30313786-B7303EE1-5DC5-44F9-BD29-2759552C7336Q34042715-6404BCFD-11E4-4407-B5A8-8AF917AF8B62Q34499632-8F85C6F6-A287-45B0-B2CC-AEADD6E7A2DDQ35667196-1914310F-4144-4F99-B4F2-61A526BD83EDQ36187063-E88B3191-26F4-4C16-85C5-97F225EA5C6BQ36207662-BC18EBF4-A900-42FB-AF37-2ED001D7B2E0Q38617840-9B0BA649-FF33-4836-9AA1-1749EBCBA1B3Q38978314-FAD78EC6-D462-41C8-BCD6-9DCCC487B74AQ39157481-0F071D4A-40A4-46FE-A328-23902B204CA3Q41498030-5211894D-208C-41D4-9867-B0C5A2F4400AQ47286823-F3A9CD4F-C88E-46E6-978D-C07B45B3CBAEQ47693752-C3BB0DB7-5F65-4CD9-B720-259702015DA7
P2860
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
German adjuvant intergroup nod ...... high-risk early breast cancer.
@ast
German adjuvant intergroup nod ...... high-risk early breast cancer.
@en
type
label
German adjuvant intergroup nod ...... high-risk early breast cancer.
@ast
German adjuvant intergroup nod ...... high-risk early breast cancer.
@en
prefLabel
German adjuvant intergroup nod ...... high-risk early breast cancer.
@ast
German adjuvant intergroup nod ...... high-risk early breast cancer.
@en
P2093
P50
P356
P1476
German adjuvant intergroup nod ...... high-risk early breast cancer.
@en
P2093
Antje Belau
Bettina Conrad
Christian Jackisch
Christoph Thomssen
Dirk Elling
Hans-Joachim Lück
Helmut Forstbauer
Ingo Bauerfeind
Ingo J Diel
Jana Barinoff
P304
P356
10.1200/JCO.2012.47.2167
P407
P577
2013-08-26T00:00:00Z